1. Home
  2. CASS vs DBVT Comparison

CASS vs DBVT Comparison

Compare CASS & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cass Information Systems Inc

CASS

Cass Information Systems Inc

N/A

Current Price

$55.47

Market Cap

714.9M

ML Signal

N/A

Logo DBV Technologies S.A.

DBVT

DBV Technologies S.A.

N/A

Current Price

$12.51

Market Cap

850.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CASS
DBVT
Founded
1906
2002
Country
United States
France
Employees
N/A
90
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.9M
850.9M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
CASS
DBVT
Price
$55.47
$12.51
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$45.00
$32.04
AVG Volume (30 Days)
64.7K
269.8K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
2.75%
N/A
EPS Growth
87.77
10.26
EPS
1.48
N/A
Revenue
$190,750,000.00
$5,636,000.00
Revenue This Year
$0.81
$35.04
Revenue Next Year
$4.39
$2,360.78
P/E Ratio
$37.38
N/A
Revenue Growth
N/A
35.77
52 Week Low
$36.07
$8.86
52 Week High
$59.63
$26.19

Technical Indicators

Market Signals
Indicator
CASS
DBVT
Relative Strength Index (RSI) 45.00 34.89
Support Level $51.22 N/A
Resistance Level $59.63 $14.90
Average True Range (ATR) 1.14 0.55
MACD -0.19 -0.19
Stochastic Oscillator 24.76 8.84

Price Performance

Historical Comparison
CASS
DBVT

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution, and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. Additionally, the firm has a banking subsidiary, offering banking services mainly to privately held businesses in the St. Louis metropolitan area and restaurant franchises and faith-based ministries within the United States. The company operates in two reportable segments: Information Services, which generates the maximum revenue, and Banking Services.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: